Establishment of an enzyme-linked immunosorbent assay for measurement of sotalol

Biol Pharm Bull. 2004 Jan;27(1):94-6. doi: 10.1248/bpb.27.94.

Abstract

We have established an enzyme-linked immunosorbent assay suitable for routine monitoring of serum levels of sotalol. Anti-sotalol antibody was obtained by immunizing rabbits with sotalol conjugated with bovine serum albumin using the N-succinimidyl ester method. An enzyme marker was similarly prepared by coupling sotalol with beta-D-galactosidase. The detection limit of sotalol by the enzyme-linked immunosorbent assay was approximately 32 ng/ml with 50-microl samples. This assay was specific for sotalol because of very slight cross-reactivity with 4-(methanesulfonylamino)benzonitrile (1.6%), but none with D,L-isoproterenol. Using this assay, drug levels were easily measured in the serum of rabbits after oral administration of sotalol at a single dose of 3 mg/kg. The enzyme-linked immunosorbent assay should be a valuable tool in therapeutic drug monitoring and pharmacokinetic studies of sotalol.

MeSH terms

  • Adrenergic beta-Antagonists / analysis*
  • Adrenergic beta-Antagonists / pharmacokinetics
  • Animals
  • Antibody Specificity
  • Biotransformation
  • Enzyme-Linked Immunosorbent Assay
  • Immunoglobulin G / analysis
  • Indicators and Reagents
  • Male
  • Rabbits
  • Sotalol / analysis*
  • Sotalol / pharmacokinetics
  • Tissue Distribution
  • beta-Galactosidase / chemistry

Substances

  • Adrenergic beta-Antagonists
  • Immunoglobulin G
  • Indicators and Reagents
  • Sotalol
  • beta-Galactosidase